MH
MHG.F Molina Healthcare Inc
- Market cap
- EUR 9.52B
- P/E
- -
- P/B
- 2.57x
- ROE
- 3.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is MHG.F undervalued?
Graham numberThe Graham number of Molina Healthcare Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Molina Healthcare Inc fundamental analysis
No fundamental analysis for Molina Healthcare Inc yet.
Molina Healthcare Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Molina Healthcare Inc
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates through Medicaid, Medicare, Marketplace, and Other segments. The company was founded in 1980 and is headquartered in Long Beach, California.
Full company profileMolina Healthcare Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Molina Healthcare Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 17.7B | 19.8B | 18.8B | 16.7B | 19.3B | 27.8B | 32.0B | 34.1B | 40.7B | 45.4B | 43.7B |
| Gross Profit | 1.80B | 1.81B | 2.50B | 2.30B | 2.60B | 3.28B | 3.93B | 4.33B | 4.74B | 4.08B | 3.75B |
| Operating Income | 268M | 79.0M | 1.07B | 918M | 1.00B | 1.02B | 1.38B | 1.57B | 1.71B | 781M | 569M |
| EBITDA | - | -316M | 1.24B | 1.15B | 1.15B | 1.13B | 1.35B | 1.74B | 1.89B | 976M | 601M |
| Net Income | 52.0M | -512M | 707M | 737M | 673M | 659M | 792M | 1.09B | 1.18B | 472M | 149M |
| EPS | - | -8.53 | 11 | 12 | 11 | 11 | 14 | 19 | 21 | 9.18 | 2.87 |
| Balance Sheet | |||||||||||
| Total Assets | 7.45B | 8.47B | 7.15B | 6.79B | 9.53B | 12.2B | 12.3B | 14.9B | 15.6B | 15.6B | 15.7B |
| Total Liabilities | 5.80B | 7.13B | 5.51B | 4.83B | 7.44B | 9.58B | 9.35B | 10.7B | 11.1B | 11.5B | 11.5B |
| Shareholders' Equity | 1.65B | 1.34B | 1.65B | 1.96B | 2.10B | 2.63B | 2.96B | 4.22B | 4.50B | 4.07B | 4.16B |
| Cash & Short-term Investments | 2.82B | 3.19B | 2.83B | 2.45B | 4.15B | 4.44B | 4.01B | 4.85B | 4.66B | 4.25B | 4.48B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 673M | 804M | -314M | 434M | 1.90B | 2.12B | 773M | 2.14B | 644M | -535M | 839M |
| Capital Expenditure | 176M | 86.0M | 30.0M | 57.0M | 74.0M | 77.0M | 91.0M | 99.0M | 100M | 101M | 125M |
| Free Cash Flow | - | 718M | -344M | 370M | 1.82B | 2.04B | 682M | 2.04B | 544M | -636M | 713M |
| Ratios | |||||||||||
| ROE | 3.2% | -38.3% | 42.9% | 37.6% | 32.1% | 25.1% | 26.7% | 25.9% | 26.2% | 11.6% | 3.6% |
| ROA | 0.7% | -6.0% | 9.9% | 10.9% | 7.1% | 5.4% | 6.4% | 7.3% | 7.5% | 3.0% | 1.0% |
| Net Profit Margin | 0.3% | -2.6% | 3.8% | 4.4% | 3.5% | 2.4% | 2.5% | 3.2% | 2.9% | 1.0% | 0.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Molina Healthcare Inc dividends
Molina Healthcare Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 3:2 on May 23, 2011.
Who owns Molina Healthcare Inc
- Insiders 1.42%
- Institutions 98.58%
- Public & others 0.00%
- Shares outstanding 52.0M
- Free float 47.9M
Molina Healthcare Inc company profile
- Company name
- Molina Healthcare Inc
- Ticker
- MHG.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 19,000
- Fiscal year end
- December
- Address
- 200 Oceangate, Long Beach, CA, United States, 90802
- Phone
- (562) 435-3666
- Website
- molinahealthcare.com
About Molina Healthcare Inc
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates through Medicaid, Medicare, Marketplace, and Other segments. The company was founded in 1980 and is headquartered in Long Beach, California.
Molina Healthcare Inc management
10- Mr. Joseph Michael ZubretskyPresident, CEO & Director · born 1957
- Mr. Mark Lowell KeimSenior EVP, CFO & Treasurer · born 1965
- Mr. James Edwin WoysSenior EVP & COO · born 1959
- Mr. Jeffrey Don Barlow Esq., J.D., M.P.H.Chief Legal Officer & Corporate Secretary · born 1963
- Ms. Debra Jean BaconExecutive Vice President of Medicaid · born 1967
- Mr. Maurice Sebastian Hebert CPAChief Accounting Officer · born 1963
- Jeffrey GeyerHead of Investor Relations
- Ms. Joann Zarza-GarridoVice President of Compliance
- Mr. Larry D. AndersonExecutive VP & Chief Human Resources Officer
- Dr. Keith Wilson M.D.Chief Medical Officer